|
|
1.
|
Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). MedStar authors:
Citation: - Circulation: Arrhythmia and Electrophysiology. 7(6):1084-91, 2014 Dec.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blasco-Colmenares E, Butcher B, Cheng A, Dalal D, Dickfeld T, Eldadah Z, Ellenbogen KA, Guallar E, Marine JE, Norgard S, Spragg DD, Tomaselli GF, Zhang Y
|
|
|
2.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
